Subsidiary of Shanghai Kehua Bio-engineering (002022.SZ) obtains a medical device registration certificate.
Kohwa Biological (002022.SZ) announced that its wholly-owned subsidiary Kohwa (Xi'an) Biotechnology Co., Ltd. has received a medical device registration certificate from the Drug Administration of Shaanxi Province for its product named: Fully Automated Chemiluminescence Immunoassay Analyzer.
Shanghai Kehua Bio-engineering (002022.SZ) announced that its wholly-owned subsidiary, Kehua (Xi'an) Bioengineering Co., Ltd., has received a medical device registration certificate issued by the Shaanxi Provincial Food and Drug Administration. The product name is: Fully automated chemiluminescence immunoassay analyzer.
Related Articles

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


